| pubmed-article:15878386 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C0687133 | lld:lifeskim |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C2745955 | lld:lifeskim |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C0123931 | lld:lifeskim |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C0069717 | lld:lifeskim |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C0008902 | lld:lifeskim |
| pubmed-article:15878386 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
| pubmed-article:15878386 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15878386 | pubmed:dateCreated | 2005-5-9 | lld:pubmed |
| pubmed-article:15878386 | pubmed:abstractText | Pharmacokinetic and pharmacodynamic drug interactions with cytotoxic drugs may significantly influence the efficacy and toxicity of chemotherapy. | lld:pubmed |
| pubmed-article:15878386 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15878386 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15878386 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15878386 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15878386 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15878386 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15878386 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15878386 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15878386 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15878386 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15878386 | pubmed:issn | 0149-2918 | lld:pubmed |
| pubmed-article:15878386 | pubmed:author | pubmed-author:BrouwersJacob... | lld:pubmed |
| pubmed-article:15878386 | pubmed:author | pubmed-author:SleijferDirk... | lld:pubmed |
| pubmed-article:15878386 | pubmed:author | pubmed-author:JansmanFrank... | lld:pubmed |
| pubmed-article:15878386 | pubmed:author | pubmed-author:CoenenJules... | lld:pubmed |
| pubmed-article:15878386 | pubmed:author | pubmed-author:IdzingaFroukj... | lld:pubmed |
| pubmed-article:15878386 | pubmed:author | pubmed-author:SmitWillem... | lld:pubmed |
| pubmed-article:15878386 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:15878386 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15878386 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:15878386 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15878386 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15878386 | pubmed:pagination | 327-35 | lld:pubmed |
| pubmed-article:15878386 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:meshHeading | pubmed-meshheading:15878386... | lld:pubmed |
| pubmed-article:15878386 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15878386 | pubmed:articleTitle | Classification and occurrence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic colorectal cancer. | lld:pubmed |
| pubmed-article:15878386 | pubmed:affiliation | Department of Clinical Pharmacy, Isala Klinieken, Zwolle, the Netherlands. f.g.a.jansman@isala.nl | lld:pubmed |
| pubmed-article:15878386 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15878386 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15878386 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15878386 | pubmed:publicationType | Multicenter Study | lld:pubmed |
